In Japan, the greatest medical advances in the treatment of malignant musculoskeletal tumors during the past 40 years have been made in high-dose chemotherapy and other related treatments, including bone marrow transplantation and gene recombinant therapy. While highdose chemotherapy can diminish or resolve lung metastases that are already present at the fi rst visit in some cases, extensive tumor resection or removal of lung metastases is eventually necessary.
Chemotherapy can be very effective; when there has been an effective response most of the tumor tissues are usually necrotized, and intralesional removal and adjuvant therapy are attempting with combined bone graft or artifi cial bone plombage. However, long-term results for the chemotherapy are not available yet. Surgical excision of low-grade malignant, well-differentiated chondrosarcomas is seen less frequently than before. These tumors can now be treated by removal with ethanol; liquid nitrogen freezing therapy; argon beam coagulation as adjuvant therapy; and fi lling with polymethyl methacrylate bone cement, beta-tricalcium phosphate (β-TCP), or hydroxyapatite.
The required surgical procedures include extensive wide resection and reconstructive surgery, taking into consideration whether loading is suitable, whether dead space is generated, and whether the cutaneous wound can be closed. The surgeon should determine the range of resection, taking into consideration the patient's clinical progress, imaging fi ndings, and pathological fi ndings. We assessed the margin of resection based on the extent of resection reported by Kawaguchi et al. 1 and found that malignant musculoskeletal tumors could be resected longitudinally to at least 5 cm away from the tumor margin. The extent of transverse resection should be 1 cm for thin fascia, 2 cm for thick fascia, and 1 cm for muscle. Transverse resection of at least 3-4 cm in total is required for high-grade malignant tumors. Any major vessels or nerves at the site of resection may require concomitant ablation or postoperative adjuvant therapy; the optimal postoperative treatment should be selected during surgery, based on the proximity of the tumor to vessels or nerves extent of separation between the tumor and the vessels or nerves. Matsumoto et al. 2 perform in situ preparation (ISP) in major vessels and nerves; if the tumor is easily separated, ethanol should be used 2-5 minutes before placing vinyl between nerves or vessels and normal tissue (1 cm margin: no recurrence).
Advances in chemotherapy boost the effect of neoadjuvant chemotherapy in cases of musculoskeletal tumors of the limbs. The affected limb can be preserved if high-dose chemotherapy is effective. An artifi cial joint is used for reconstruction. Owing to extensive tissue loss in the pelvic or hip regions, controllable joint systems are used near the femur. The outcome is relatively stable, and survival of 10 years or longer has been reported in some patients. Arthrodesis was used about 20 to 30 years ago, when it was not yet possible to perform stable artifi cial joint arthroplasty. Around the same time, allogeneic bone transplantation was introduced. Complications were reported in 30% of patients. Such transplants are useful in patients who do not require chemotherapy. In Japan, allogeneic bone transplantation is diffi cult, and recycled bone is used. Various methods are available, such as curettage the largest part of the removed bone tumor and immersing the remaining bone in frozen liquid nitrogen (15 min), or repairing the removed bone by applying high-dose radiation or a Pasteur water bath (60°C for 20 min) to it for internal fi xation. These procedures may have poor results without the concomitant use of a vascularized bone graft.
The timing of surgical treatment varies slightly among patients. In Japan, the usual course of treatment consists of two to three cycles of neoadjuvant chemotherapy, surgery, and four to fi ve cycles of postoperative chemotherapy, in this order. Patients who develop infection after extensive tumor resection cannot receive postoperative chemotherapy, and amputation may be required. The risk of infection can be minimized by using a vascularized fi bular graft, a vascularized iliac graft, or a musculocutaneous fl ap. In some cases, adequate chemotherapy is continued as long as it is effective and this leads to surgery as the fi nal step. A delay in postoperative chemotherapy due to surgical complications must be avoided. Surgery after adequate neoadjuvant chemotherapy is highly recommended, particularly for the removal of trunk or pelvic tumors, total femoral replacement, and in patients with lung metastases.
Advances in spinal surgery depend largely on advances in the instruments. After the application of a threadwire saw (T-saw) to tumor resection, as reported by Tomita and Kawahara, 3 spinal tumors can be removed safely without severe stress on the tumors, while protecting the spinal cord. We employ a modifi ed T-saw 4 that was designed by adding some modifi cations to the T-saw. Sacral chordomas showing frequent recurrence were extremely diffi cult to remove surgically. Among our patients with such tumors, 11 patients had had the disease for at least 10 years. The survival time was 10 years or longer in 6 patients; the survival rate was 55% by Kaplan-Meier analysis. One man (69 years old) died of another disease after a 6-year survival. Apart from this elder and high grade chordoma patients, approximately 65% of our patients survived the disease. Patients with concurrent bladder disorders have a high risk of pyelonephritis and may suffer from fecal incontinence; these problems can interfere with their employment. T-saw can shorten the surgery time, decrease the amount of blood loss, and allow nerves to be preserved to a lower level in comparison with conventional resection methods, reducing the recurrence rate and improving postoperative function. Carbon ion radiotherapy is less likely than surgery to cause functional impairment, particularly in cases of chordoma. Its long-term outcome after 10 years or longer is not available yet, and the therapy carries the risk of complications, such as skin disorders and neurogenic pain. The therapy is a good option for patients requiring extensive tumor removal that may result in impaired function or recurrence. However, surgical resection is recommended if the nerves at sacral level 3 and higher can be preserved.
In pediatric patients, osteosarcoma and Ewing's sarcoma are the common malignant musculoskeletal tumors of tumor prosthesis. In these patients, neoadjuvant chemotherapy is important. After surgical resection, an expanding tumor prosthesis is implanted, and many problems remain with the extension of tumor prosthesis. In children, unequal leg length causes a problem. Tsuchiya et al. 5 reported limb lengthening by external skeletal fi xation in their patients, including both children and adults. For lesions in the diaphysis, a vascularized fi bular graft may be a favorable option.
Minimally invasive surgery is effective for benign tumors but involves such problems as the time required for surgery, and the risk of recurrence for aggressive tumors. This procedure is also applied to cases of malignant tumors for which chemotherapy is extremely effective, as mentioned above.
As promising treatments, gene therapy and vaccine therapy have been shown to be effective for metastases from low-grade malignant tumors. Medical advances are limitless. We must make every effort to advance.
The 43rd Annual Musculoskeletal Tumor Meeting of the Japanese Orthopaedic Association, which is a traditional academic meeting, will be held on July 15 (Thursday) and 16 (Friday), 2010, at the Keio Plaza Hotel Tokyo in Shinjuku, Tokyo, Japan. The theme of the meeting is "Challenges in the surgical treatment of diffi cult malignant musculoskeletal tumors and training of young doctors." The original intention of surgical therapy is to save patients suffering from diseases. We must face diffi cult cases of malignant tumors. The surgical techniques needed for these challenges are not easy. Each surgeon should not only comprehend the patient's general condition, but also the tumor characteristics, imaging fi ndings, and histopathological data. Ligation of a single vessel is an important step. The surgeon should perform surgery responsibly until the last, though it is long time surgery. Such an attitude can lead to successful surgery. The abstracts of the meeting include outlines of many changes in diagnostic methods and new treatments. At this meeting, we will be pleased to transmit our enthusiasm as surgeons to young doctors, to prepare them for diffi cult surgery.
